Premium
Testing new susceptibility genes in the cohort of apparently sporadic phaeochromocytoma/paraganglioma patients with clinical characteristics of hereditary syndromes
Author(s) -
Pęczkowska Mariola,
Kowalska Aldona,
Sygut Jacek,
Waligórski Dariusz,
Malinoc Angelica,
JanaszekSitkowska Hanna,
Prejbisz Aleksander,
Januszewicz Andrzej,
Neumann Hartmut P. H.
Publication year - 2013
Publication title -
clinical endocrinology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.055
H-Index - 147
eISSN - 1365-2265
pISSN - 0300-0664
DOI - 10.1111/cen.12218
Subject(s) - sdhb , sdhd , paraganglioma , pheochromocytoma , medicine , germline mutation , allele , pathology , genetics , gene , endocrinology , mutation , gastroenterology , biology
Background Phaeochromocytoma ( PCC ) and paraganglioma ( PGL ) can occur sporadically or as a part of familial cancer syndromes. Red flags of hereditary syndromes are young age and multifocal tumours. We hypothesized that such patients are candidates for further molecular diagnosis in case of normal results in ‘classical’ genes. Material and methods We selected patients with PCC / PGL under the age of 40 and/or with multiple tumours. First, we tested the genes RET , VHL , NF 1, SDHB , SDHC and SDHD . Patients without mutations in these genes were tested for mutations in MAX , TMEM 127 and SDHAF 2 . Results In 153 patients included, mutations were detected in the classical genes in 72 patients (47%) [ RET ‐22 (14%), VHL ‐13 (9%), NF 1 ‐3 (2%), SDHB ‐13 (9%), SDHC ‐3 (2%), SDHD ‐16 (11%), SDHB large deletions– 2 (1%)]. One patient with MAX c.223C>T (p.R75X) mutation was detected. It was a male with bilateral, metachronous phaeochromocytomas diagnosed in 36 and 40 years of age. Remarkably, he showed in the period before the MAX gene was detected, a RET p. Y 791 F variant. During 10‐year follow‐up, we did not find any thyroid abnormalities. LOH examination of tumour tissue showed somatic loss of the wild‐type allele of MAX . Conclusion Analysis of the MAX gene should be performed in selected patients, especially those with bilateral adrenal phaeochromocytoma in whom mutations of the classical genes are absent. Our study provides with further support that Y 791 F RET is a polymorphism.